Skip to content

Clinical trials

Completed Phase 3 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Phase: Phase 3 Status: Completed Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20101
20122
20131
20141
20152
20161
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring3
National Center for Research Resources (NCRR)3
Baxalta now part of Shire2
Centre Hospitalier Universitaire de Saint Etienne1
Grifols Therapeutics LLC1
Istituto Clinico Humanitas1
Laboratoire français de Fractionnement et de Biotechnologies1
Nihon Pharmaceutical Co., Ltd1
Novartis Pharmaceuticals1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating15
Rare Diseases4
Mental Disorders3
Neurologic Manifestations3
Peripheral Nervous System Diseases2
Polyradiculoneuropathy2
Autoimmune Diseases1
Autoimmune Diseases of the Nervous System1
Demyelinating Diseases1
Immune System Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.